Comment on “Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results” by J.-M. Nabholtz et al.

✍ Scribed by H.T. Mouridsen; H.A. Chaudri-Ross

• Book ID: 116428010
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 100 KB
• Volume: 40
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2003.09.040